Cargando…
Scaling the immune incline in PDAC
Pancreatic ductal adenocarcinoma (PDAC) reflects the current challenge for immuno-oncology: to develop new drugs for cancers that are resistant to current immunotherapies. Here, we argue for a need to use patients to uncover new strategies that activate anti-tumour immunity.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173858/ https://www.ncbi.nlm.nih.gov/pubmed/34083798 http://dx.doi.org/10.1038/s41575-021-00475-9 |
| _version_ | 1783702792577220608 |
|---|---|
| author | Rojas, Luis A. Balachandran, Vinod P. |
| author_facet | Rojas, Luis A. Balachandran, Vinod P. |
| author_sort | Rojas, Luis A. |
| collection | PubMed |
| description | Pancreatic ductal adenocarcinoma (PDAC) reflects the current challenge for immuno-oncology: to develop new drugs for cancers that are resistant to current immunotherapies. Here, we argue for a need to use patients to uncover new strategies that activate anti-tumour immunity. |
| format | Online Article Text |
| id | pubmed-8173858 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81738582021-06-04 Scaling the immune incline in PDAC Rojas, Luis A. Balachandran, Vinod P. Nat Rev Gastroenterol Hepatol Comment Pancreatic ductal adenocarcinoma (PDAC) reflects the current challenge for immuno-oncology: to develop new drugs for cancers that are resistant to current immunotherapies. Here, we argue for a need to use patients to uncover new strategies that activate anti-tumour immunity. Nature Publishing Group UK 2021-06-03 2021 /pmc/articles/PMC8173858/ /pubmed/34083798 http://dx.doi.org/10.1038/s41575-021-00475-9 Text en © Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Comment Rojas, Luis A. Balachandran, Vinod P. Scaling the immune incline in PDAC |
| title | Scaling the immune incline in PDAC |
| title_full | Scaling the immune incline in PDAC |
| title_fullStr | Scaling the immune incline in PDAC |
| title_full_unstemmed | Scaling the immune incline in PDAC |
| title_short | Scaling the immune incline in PDAC |
| title_sort | scaling the immune incline in pdac |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173858/ https://www.ncbi.nlm.nih.gov/pubmed/34083798 http://dx.doi.org/10.1038/s41575-021-00475-9 |
| work_keys_str_mv | AT rojasluisa scalingtheimmuneinclineinpdac AT balachandranvinodp scalingtheimmuneinclineinpdac |